Wharton M: The epidemiology of varicella-zoster virus infections. Infect Dis Clin North Am. 1996, 10: 571-581. 10.1016/S0891-5520(05)70313-5.
Article
CAS
PubMed
Google Scholar
Galil K, C Brown, F Lin, J Seward: Hospitalizations for varicella in the United States, 1988 to 1999. Pediatr Infect Dis J. 2002, 21: 931-934. 10.1097/00006454-200210000-00009.
Article
PubMed
Google Scholar
Meyer PA, Seward JF, Jumaan AO, Wharton M: Varicella mortality: trends before vaccine licensure in the United States, 1970–1994. J Infect Dis. 2000, 182: 383-390. 10.1086/315714.
Article
CAS
PubMed
Google Scholar
Davis MM, Patel MS, Chem BS, Gebremariam A: Decline in varicella-related hospitalizations and expenditures for children and adults after introduction of varicella vaccine in the United States. Pediatrics. 2004, 114: 786-792. 10.1542/peds.2004-0012.
Article
PubMed
Google Scholar
Gilden DH, Kleinschmidt-DeMasters BK, LaGuardia JJ, Mahalingam R, Cohrs RJ: Neurologic complications of the reactivation of varicella-zoster virus. N Engl J Med. 2000, 342: 635-645. 10.1056/NEJM200003023420906.
Article
CAS
PubMed
Google Scholar
Donahue JG, Choo PW, Manson JE, Platt R: The incidence of herpes zoster. Arch Intern Med. 1995, 155: 1605-1609. 10.1001/archinte.155.15.1605.
Article
CAS
PubMed
Google Scholar
Centers for Disease Control and Prevention: Evaluation of varicella reporting to the National Notifiable Disease Surveillance System – United States, 1972–1997. Morb Mortal Wkly Rep. 1999, 48: 55-58.
Google Scholar
Food and Drug Administration: Summary for Basis of Approval. Reference number: 93-0395, [http://www.fda.gov/cber/sba/varmer031795sba.pdf]
Centers for Disease Control and Prevention: National, state, and urban area vaccination levels among children aged 19–35 months – United States, 2003. Morb Mortal Wkly Rep. 2004, 53: 658-661.
Google Scholar
McGregor RM: Herpes zoster, chicken-pox, and cancer in general practice. Br Med J. 1957, 32: 84-87.
Article
Google Scholar
Hope-Simpson RE: The nature of herpes zoster: A long-term study and a new hypothesis. Proc R Soc Med. 1965, 58: 9-20.
CAS
PubMed
PubMed Central
Google Scholar
Ragozzino MW, Melton LJ, Kurland LT, Chu CP, Perry HO: Population-based study of herpes zoster and its sequelae. Medicine (Baltimore). 1982, 61: 310-316.
Article
CAS
Google Scholar
Chidiac C, Bruxelle J, Daures JP, Hoang-Xuan T, Morel P, Lepiege A, El Hasnaoui A, de Labareyre C: Characteristics of patients with herpes zoster on presentation to practitioners in France. Clin Infect Dis. 2001, 33: 62-69. 10.1086/320884.
Article
CAS
PubMed
Google Scholar
Gershon AA, LaRussa P, Steinberg S, Mervish N, Lo SH, Meier P: The protective effect of immunologic boosting against zoster: An analysis in leukemic children who were vaccinated against chickenpox. J Infect Dis. 1996, 173: 450-453.
Article
CAS
PubMed
Google Scholar
Thomas SL, Wheeler JG, Hall AJ: Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study. Lancet. 2002, 360: 678-682. 10.1016/S0140-6736(02)09837-9.
Article
PubMed
Google Scholar
Brisson M, Gay NJ, Edmunds WJ, Andrews NJ: Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox. Vaccine. 2002, 20: 2500-2507. 10.1016/S0264-410X(02)00180-9.
Article
CAS
PubMed
Google Scholar
Brunell PA, Taylor J, Geiser CF, Frierson L, Lydick E: Risk of herpes zoster in children with leukemia: varicella vaccine compared with history of chickenpox. Pediatrics. 1986, 77: 53-65.
CAS
PubMed
Google Scholar
Lawrence R, Gershon AA, Holzman R, Steinberg SP, the NIAID Varicella Vaccine Collaborative Study Group: The risk of zoster after varicella vaccination in children with leukemia. N Engl J Med. 1988, 318: 543-548.
Article
CAS
PubMed
Google Scholar
Hardy I, Gershon AA, Steinberg SP, LaRussa PL, the Varicella Vaccine Collaborative Study Group: The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. N Engl J Med. 1991, 325: 1545-1550.
Article
CAS
PubMed
Google Scholar
Plotkin SA, Starr SE, Connor K, Morton D: Zoster in normal children after varicella vaccine. J Infect Dis. 1989, 159: 1000-1001.
Article
CAS
PubMed
Google Scholar
Gershon A, Silverstein S: Live attenuated varicella vaccine for prevention of herpes zoster. Biologicals. 1997, 25: 227-230. 10.1006/biol.1997.0089.
Article
CAS
PubMed
Google Scholar
Finger R, Hughes JP, Meade BJ, Pelletier AR, Palmer CT: Age-specific incidence of chickenpox. Public Health Reports. 1994, 109: 750-755.
CAS
PubMed
PubMed Central
Google Scholar
Smith PJ, Battaglia MP, Huggins VJ, Hoagland DC, Roden A, Khare M, Ezzati-Rice TM, Wright RA: Overview of the sampling design and statistical methods used in the National Immunization Survey. Am J Prev Med. 2001, 20: 61-69. 10.1016/S0749-3797(01)00285-9.
Article
Google Scholar
Powell-Griner E, Anderson JE, Murphy W: State and sex-specific prevalence of selected characteristics – Behavioral Risk Factor Surveillance System, 1994 and 1995. CDC Surveillance Summary, August 1, 1997. Morb Mortal Wkly Rep. 1997, 46: 1-31.
CAS
Google Scholar
Klein RJ, Schoenborn CA: Age adjustment using the 2000 projected U.S. population. Statistical Notes. 20: 1-10. [http://www.cdc.gov/nchs/data/statnt/statnt20.pdf]
Centers for Disease Control and Prevention, National Immunization Program. [http://www.cdc.gov/nip/coverage/nis/03/tab03_antigen_state.xls]
Guess HA, Broughton DD, Melton LJ, Kurland LT: Population-based studies of varicella complications. Pediatrics. 1986, 78 (suppl): 723-727.
CAS
PubMed
Google Scholar
Yawn BP, Yawn RA, Lydick E: The community impact of childhood varicella infections. J Pediatrics. 1997, 130: 759-765.
Article
CAS
Google Scholar
Choo PW, Donahue JG, Manson JE, Platt R: The epidemiology of varicella and its complications. J Infect Dis. 1995, 172: 706-712.
Article
CAS
PubMed
Google Scholar
Seward JF, Watson BM, Peterson CL, Mascola L, Pelosi JW, Zhang JX, Maupin TJ, Goldman GS, Tabony LJ, Brodovicz KG, Jumaan AO, Wharton M: Varicella disease after introduction of varicella vaccine in the United States, 1995–2000. JAMA. 2002, 287: 606-611. 10.1001/jama.287.5.606.
Article
PubMed
Google Scholar
Jumaan AO, Yu O, Jackson LA, Bohlke K, Galil K, Seward JF: Herpes zoster incidence before and after declines in varicella incidence associated with varicella vaccination, 1992–2002. J Infect Dis.
Centers for Disease Control and Prevention: Decline in annual incidence of varicella – selected states, 1990–2001. Morb Mortal Wkly Rep. 2003, 52: 884-885.
Google Scholar
Clements DA, Zaref JI, Bland CL, Walter EB, Coplan P: Partial uptake of varicella vaccine and the epidemiological effect on varicella disease in 11 day-care centers in North Carolina. Arch Pediatr Adolesc Med. 2001, 155: 433-461.
Article
Google Scholar
Ryan MA, Smith TC, Honner WK, Gray GC: Varicella susceptibility and vaccine use among young adults enlisting in the United States Navy. J Med Virol. 2003, S15-19. 10.1002/jmv.10314. Suppl 1
Opstelten W, Mauritz JW, de Wit NJ, van Wijck AJM, Stalman WAB, van Essen GA: Herpes zoster and postherpetic neuralgia: incidence and risk indicators using a general practice research database. Fam Pract. 2002, 19: 471-475. 10.1093/fampra/19.5.471.
Article
PubMed
Google Scholar
Garnett GP, Grenfell BT: The epidemiology of varicella-zoster virus infection: The influence of varicella on the prevalence of herpes zoster. Epidemiol Infect. 1992, 108: 513-528. See pp. 521–522
Article
CAS
PubMed
PubMed Central
Google Scholar
Brisson M, Edmunds WJ, Law B, Gay NJ, Walld R, Brownell M, Roos L, de Serres G: Epidemiology of varicella zoster virus infection in Canada and the United Kingdom. Epidemiol Infect. 2001, 127: 305-314.
Article
CAS
PubMed
PubMed Central
Google Scholar
Jumaan AO, Seward JF, Wooten K, Chen J, Singleton JA: Varicella and herpes zoster surveillance in the U.S., 1970–1994. Presented at 41st Annual Meeting of IDSA, October 9–12, 2003. San Diego, CA, Abstract # 899
Woolsey TD, Lawrence PS, Balamuth E: An evaluation of chronic disease prevalence data from the health interview survey. Am J Public Health. 1962, 52: 1631-1637.
Article
CAS
Google Scholar
Halabi S, Zurayk H, Awaida R, Darwish M, Saab B: Reliability and validity of self and proxy reporting of morbidity data: a case study from Beirut, Lebanon. Int J Epidemiol. 1992, 21: 607-12.
Article
CAS
PubMed
Google Scholar
Schmader K, George LK, Newton R, Hamilton JD: The accuracy of self-report of herpes zoster. J Clin Epidemiol. 1994, 47: 1271-1276. 10.1016/0895-4356(94)90132-5.
Article
CAS
PubMed
Google Scholar
Zhang Z, Cohen B: How representative is the Massachusetts BRFSS sample: a comparison to the current census data. 2003, Presented at BRFSS Annual Conference, St. Louis, MO
Google Scholar
Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, Arbeit RD, Simberkoff MS, Gershon AA, Davis LE, Weiberg A, Boardman KD, et al: A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005, 352: 2271-2284. 10.1056/NEJMoa051016.
Article
CAS
PubMed
Google Scholar
Gilden DH: Varicella-zoster virus vaccine – grown-ups need it, too. N Engl J Med. 2005, 352: 2344-2346. 10.1056/NEJMe058090.
Article
CAS
PubMed
Google Scholar
Arvin A: Aging, immunity, and the varicella-zoster virus. N Engl J Med. 2005, 352: 2266-2267. 10.1056/NEJMp058091.
Article
CAS
PubMed
Google Scholar